Stanford University
Showing 8,101-8,200 of 13,157 Results
-
Hesam N. Motlagh
Adjunct Professor, Structural Biology
BioHesam is passionate about translating basic science discoveries into products that have a significant impact on society. He is Chief of Staff at Khosla Ventures where he works with Vinod Khosla on strategic projects for the firm and advises portfolio companies on fundraising, product, business development, marketing, and general strategy.
Currently, Hesam is an Adjunct Professor in the Department of Structural Biology at Stanford Medicine and a Fellow in The Johns Hopkins Institute for Applied Economics, Global Health, and the Study of Business Enterprise where he is editor of the Studies in Applied Finance. Previously, he worked on financial and corporate strategy at Seer Biosciences and was a Pear Fellow at Pear VC. Before Seer, he was a quant at an investment management firm after being a molecular and computational biophysicist for almost a decade.
Hesam has many peer-reviewed publications including a review article that was highlighted on the cover of Nature. He completed his MBA at Stanford Graduate School of Business, obtained his PhD from the Program in Molecular Biophysics at The Johns Hopkins University under the supervision of Vincent Hilser, and obtained his undergraduate degrees from Miami University in Oxford, Ohio. -
Liesl Nel-Themaat, PhD, HCLD, MBA
Clinical Associate Professor, Obstetrics & Gynecology - Reproductive Endocrinology & Infertility
BioDr. Nel-Themaat has been in the field of assisted reproduction for more than 20 years, with the past 11 years in clinical IVF. She possesses a unique combination of a strong academic background, broad technical experience and extensive leadership, and management training. Through a multi-dimensional approach, she has helped to improve patient care and outcomes in Assisted Reproductive Technology (ART).
Dr. Nel-Themaat was most recently employed as the Regional IVF Lab Director for Shady Grove Fertility in Colorado and served as the IVF Lab Director at University of Colorado Advanced Reproductive Medicine. She received her PhD from LSU, Baton Rouge and recently completed an Executive Masters of Business Administration program at the University of Denver.
Her goal is to advance the field “by building strong, high performing lab teams, by carefully evaluating and adapting appropriately to industry trends, by training and educating the current and next generations, and by participating in collaborative research that enhances our understanding of reproduction.”
In her free time, Dr. Nel-Themaat loves to spend time with her husband and two children, preferably in nature. With them, she enjoys skiing, hiking, biking, swimming and anything nature has to offer. She likes to cook out and introduce our American friends to South African cuisine, especially a “braai,” which is their version of a BBQ. During school holidays, she likes to visit family in South Africa, go on safari and enjoy the beautiful beaches. Dr. Nel-Themaat enjoys jamming on the piano, guitar, drums and microphone with her family. She also considers herself very competitive and loves playing and watching sports or playing board games. -
Drew Nelson
Professor of Mechanical Engineering, Emeritus
BioResearch involves development of improved methods for predicting the fatigue life of engineering materials, incuding the effects of manufacturing processes, and investigation of new approaches in the field of experimental mechanics, such as determination of residual stresses using optical methods.
-
Joanna Nelson
Clinical Associate Professor, Medicine - Infectious Diseases
BioDr. Nelson is a board certified Infectious Disease specialist. She specializes in the treatment of immunocompromised patients, including patients who have had solid organ or bone marrow transplantation or who have malignancy undergoing chemotherapy. She also has a special interest in caring for patients with Cystic fibrosis or who have had a lung transplant as well as Nontuberculous mycobacterial Infections.
-
Lorene Nelson, PhD, MS
Professor of Epidemiology and Population Health, Emerita
Current Research and Scholarly InterestsPrimary research interests:
- genetic, environmental and lifestyle determinants of neurodegenerative disorders
(amyotrophic lateral sclerosis, multiple sclerosis, Parkinson's disease, migraine)
- innovative study design and data ecosystems in clinical and public health
Primary educational interests:
- Training of next generation scientists in advanced data science and analytic methods
in population, social, and behavioral health sciences. -
Carter Neugarten
Clinical Associate Professor, Medicine - Primary Care and Population Health
BioDr. Neugarten is a recognized healthcare leader and national expert at the crossroads of palliative care and emergency medicine. He has published widely in this field, and his initiatives focus on enhancing upstream palliative care accessibility, resource optimization in healthcare, and harnessing telemedicine's potential in providing care.
His contributions include co-chairing a national committee that fosters innovation by merging these fields, and he has received grant funding to study the impact of palliative care referral from the ED.
Dr. Neugarten also has an established footprint in medical education, having held multiple formal teaching roles throughout his career. -
Gernot Neumayer
Sr Res Scientist-Basic Life, Stem Cell Bio Regenerative Med Institute
Current Role at StanfordSenior Scientist
-
Andrew Nevins
Clinical Professor, Medicine - Infectious Diseases
Current Research and Scholarly InterestsClinical general infectious diseases. Medical education.
-
Jennifer A. Newberry
Associate Professor of Emergency Medicine (Adult Clinical/Academic)
Current Research and Scholarly InterestsInterests include global emergency care systems development and workforce, epidemiology of emergency conditions in LMICs, prehospital care and health equity, gender-based violence, mental health, help-seeking behaviors, community health workers
-
Aaron Newman
Associate Professor of Biomedical Data Science
Current Research and Scholarly InterestsOur group develops computational strategies to study the phenotypic diversity, differentiation hierarchies, and clinical significance of tumor cell subsets and their surrounding microenvironments. Key results are further explored experimentally, both in our lab and through collaboration, with the ultimate goal of translating promising findings into the clinic.
-
Lesley Park
Affiliate, Epidemiology and Population Health
BioStanford Advancing Health Equity and Diversity (AHEaD)
ahead.stanford.edu
Founding Co-Director (2020-present)
Veterans Aging Cohort Study (VACS)
Executive Director (2022-present)
Cancer Core Co-Director (2016-present)
International Workshop on HIV and Hepatitis Observational Databases (IWHOD)
iwhod.org
Chair, Scientific Secretariat (2024-present)
Dr. Lesley Park is a co-founding director of the Stanford AHEaD summer research program for college students from underrepresented and historically excluded groups in the health sciences. She is also the Executive Director of the VACS consortium, an international collaboration of methodologists, clinicians, and trainees who utilize the rich and valuable data from the Veterans Health Administration to do impactful research. VACS has been at the forefront of research to understand aging with HIV to improve patient care, particularly with respect to alcohol and other substance use, physiologic frailty, and polypharmacy. In recent years, the VACS mission has expanded to encompass other foci, including genomic research and most recently COVID-19.
Within the VACS, Dr. Park oversees cancer and COVID-19 outcomes research in persons with HIV/AIDS (PWH). Her research experience has focused on the intersection of cancer and HIV, examining epidemiologic methods for cancer research, cancer incidence trends, and cancer (particularly hepatocellular carcinoma) prevention in PWH. Dr. Park is an experienced epidemiologist, skilled in "big data" observational research, survival analysis, and SAS programming. She teaches courses in computing, data management, and epidemiologic analysis methods. Her prior experience includes research at the Yale School of Medicine and at the Center for Biostatistics in AIDS Research (CBAR) at the Harvard School of Public Health.
The International Workshop on HIV and Hepatitis Observational Databases (IWHOD) is an established scientific forum for the appropriate application of real-world data to emerging issues in infectious disease. Dr. Park leads the IWHOD scientific committee of internationally reknowned experts in infectious disease and is responsible for administrative and scientific coordination of IWHOD.
Previously, Dr. Park was one of the leaders of the Stanford Center for Population Health Sciences (PHS). PHS aims to improve the health of populations by bringing together diverse disciplines and data to understand and address social, environmental, behavioral, and biological factors. She oversaw all of the educational and training initiatives at PHS and was one of the founding directors of the PHS Data Center and PHS Postdoctoral Fellowship program. -
Jordan L. Newmark, MD, QME
Adjunct Clinical Associate Professor, Anesthesiology, Perioperative and Pain Medicine
Current Research and Scholarly InterestsClinical Interests:
Chronic & perioperative pain, interdisciplinary & procedural pain treatment, trauma anesthesia, spine surgery anesthesia, CRPS, nerve injury
Academic Interests:
- Graduate & undergraduate medical education, medical simulation & immersive learning, performance assessment & evaluation, adult learning theory, clinician selection processes, patient safety & quality of care, health equity -
William Newsome
Harman Family Provostial Professor and Professor of Neurobiology and, by courtesy, of Psychology
Current Research and Scholarly InterestsNeural processes that mediate visual perception and visually-based decision making. Influence of reward history on decision making.
-
Jessica Ng, MD
Clinical Assistant Professor, Adult Neurology
BioDr. Ng is a board-certified, fellowship-trained neurologist with Stanford Health Care Movement Disorders Center and Stanford Health Care Neurology in Pleasanton. She is also a clinical assistant professor in the Department of Neurology and Neurological Sciences at Stanford University School of Medicine.
Dr. Ng provides comprehensive care for people with movement disorders. She diagnoses and treats a wide range of movement disorders, including ataxia, atypical parkinsonism, dystonia, essential tremor, Huntington’s disease, and Parkinson’s disease. She specializes in assessing patients for minimally invasive treatments, including botulinum toxin therapy, deep brain stimulation (DBS), and MR-guided focused ultrasound (MRgFUS).
Dr. Ng’s research interests include assessing treatment and diagnostic tools for Parkinson’s disease and other movement disorders.
Dr. Ng has presented to her peers at international and national meetings, including the International Congress of Parkinson’s Disease and Movement Disorders, the American Academy of Neurology, and the American Epilepsy Society. She is also a passionate clinician educator who has given lectures to medical students, physician assistant students, residents, and community physicians.
Dr. Ng is a member of the American Academy of Neurology and the International Parkinson and Movement Disorder Society. -
Madelena Ng
Postdoctoral Scholar, Biomedical Ethics
BioDr. Madelena Ng is a Postdoctoral Scholar and NHGRI T32 ELSI Research Fellow at the Laurie J. Girand Center for Biomedical Ethics (GCBE) at Stanford. Dr. Ng is an applied health scientist whose work evaluates the real-world impact of emerging technologies on people and society. Her research has consistently shown that technological solutions alone are insufficient in addressing the shortcomings inherent in the biomedical research ecosystem.
Prior to Dr. Ng's appointment at GCBE, she was a Postdoctoral Scholar at the Stanford Division in Computation Medicine leading foundational work in AI ethics, governance, and responsible innovation. She will further her training in ELSI research at the intersection of generative biology, multisector research practices, and regulation. As generative AI continues to advance rapidly, she aims to embed ethics into the core of health AI development, operations, and decision-making. -
Billy Ng
Affiliate, Medicine - Med/Oncology
BioLab website: https://ngwailung.com/
Professor Billy Ng is currently a Visiting Associate Professor at Stanford University. He completed his postdoctoral training at Harvard Medical School and the University of Oxford, following his Ph.D. and B.Sc. (1st Hons) in Chemistry from The Chinese University of Hong Kong (CUHK). During his graduate studies, he was also a Fulbright Scholar at the Massachusetts Institute of Technology (MIT). He was recognized as a Young Global Leader by the World Economic Forum and received the Academic Young Investigator Award from the American Chemical Society (ACS) Division of Organic Chemistry.
Professor Ng’s research interests are chemical biology, drug discovery, and carbohydrate chemistry. He uses chemical and biological tools to develop novel small molecules for the treatment of various diseases, including cancers, infectious and neurodegenerative diseases. He has co-authored more than 30 papers in prestigious journals such as Science, Nature Chemical Biology, Molecular Cell, J. Am. Chem. Soc., Angew. Chem. Int. Ed., and ACS Central Science. His research has been funded by diverse sources, including the Bill & Melinda Gates Foundation, US National Academy of Medicine (NAM), the Innovation and Technology Fund (ITF), and Research Grants Council (RGC) of Hong Kong. -
Christine Ngaruiya
Associate Professor of Emergency Medicine (Adult Clinical Academic)
BioChristine Ngaruiya, MD, MSc, DTM&H is the Director of the Stanford EM International Global and Population Health Section (SEMI), and Associate Professor, in the Stanford Department of Emergency Medicine (DEM).
Previously she was on faculty in the Department of Emergency Medicine (DEM) at Yale University. She completed the Global Health and International Emergency Medicine fellowship in the Yale DEM in 2015, while also matriculating with a Master of Science and Diploma in Tropical Medicine and International Health from the London School of Hygiene and Tropical Medicine. Her research interests center on: noncommunicable diseases (NCDs), barriers to care, community-based participatory research and implementation science with a particular focus on Africa.
Some past honors include: the Emergency Medicine Resident’s Association (EMRA) Augustine D’Orta Award for outstanding community and grassroots involvement, Harambe Entrepreneur Alliance Associate and the 2014 Harambe Pfizer Fellow Award for social entrepreneurship, the 2016 University of Nebraska Outstanding International Alumnus award, the 2018 Young Physician award of the Global Emergency Medicine Academy at the Society for Academic Emergency Medicine, the 2019 Yale School of Medicine Leonard Tow Humanism in Medicine for clinical excellence and compassionate care, being selected as 1 of 30 WomenLift Health Women Leaders in Global Health in 2021, 1 of 25 US Schmidt Futures International Strategy Forum fellows in 2023, and as 1 of 100 National Academy of Sciences US-Africa Frontiers in STEM fellows in 2024.
She has held several national and international leadership positions including with: the Society of Academic Emergency Medicine, the Consortium of Universities for Global Health (CUGH) as current co-chair of the Research Committee (2024-2026), the African Federation for Emergency Medicine (AFEM) and WomenLift Health. She was also a founding member of the Yale Network for Global Noncommunicable Disease (NGN). Her work has been funded by Yale University, the NIH (top 100 in Emergency Medicine), Gates Foundation, World Bank, USAID, the American Psychiatric Association, among others. She has served on a number of NIH panels related to global NCD topics, and has lectured both nationally and internationally on the same. Currently, she is a member of a World Health Organization (WHO) group developing an implementation science research agenda for global NCDs.
She is the global NCD section editor for PLOS Global Public Health, and also a fervent writer in the non-traditional sphere on global NCDs. To that end, she was selected as one of twenty Yale Public Voice Fellows for 2015-2016 from across campus with more than 20 publications in outlets such as Time, Huffington Post, Medium, and The Hill on the topic. -
Andrew Thai Nguyen
Clinical Scholar, Medicine - Cardiovascular Medicine
Postdoctoral Scholar, Cardiovascular MedicineBioDr. Andrew Nguyen is a Cardiologist and a Clinical Scholar in the Department of Medicine, Division of Cardiovascular Medicine. He earned his medical degree from Harvard Medical School in the Harvard-MIT Health Sciences and Technology Program. He then completed his residency in Internal Medicine at Stanford University, followed by fellowship training in Cardiovascular Medicine also at Stanford University.
As a non-invasive cardiologist, Dr. Nguyen cares for patients undergoing cancer therapy as well as cancer survivors in the Stanford Health Care Cardio-Oncology Program. He provides evidenced-based cardiovascular care for patients throughout their cancer journey while managing and preventing treatment toxicities. Dr. Nguyen is a physician scientist who is mentored by Dr. Paul Cheng and Dr. Tom Quertermous. His research blends his clinical interest in cardio-oncology with basic science to understand the complex interplay between cancer angiogenesis and ischemic heart disease. He is a recipient of the AHA Postdoctoral Fellowship Award, ACC/Merck Research Fellowship Award, and NIH F32 Award. -
Dung Nguyen
Clinical Professor, Surgery - Plastic & Reconstructive Surgery
BioDr. Dung H Nguyen is currently the Director of Breast Reconstruction at the Stanford Women’s Cancer Center, Director of Microsurgery and Microsurgery Fellowship, and the Director of Adult Plastics Clinic at Stanford Healthcare. She graduated with a Bachelor of Science in Biochemistry and highest academic honor and distinction from U.C. Davis. She earned a Pharm.D degree from U.C.S.F. School of Pharmacy and a MD degree from U.C.S.D. She then did a residency in general surgery and a residency in Plastic and Reconstructive Surgery at the University of Southern California (USC) Medical Center. She further completed a fellowship in microsurgery from Chang Gung Memorial Hospital in Taiwan, one of the largest reconstructive surgery centers in the world. She was recruited to Stanford from Cedar Sinai Medical Center in 2012, and is currently a Clinical Professor in the Division of Plastic and Reconstructive Surgery at Stanford University.
Dr. Nguyen specializes in aesthetic and reconstructive breast surgery, surgical treatment of lymphedema including vascularized lymph node transfer and lymphaticovenous anastomosis, and complex tissue reconstruction utilizing microsurgery and supermicrosurgery. She also has interest in cosmetic surgery, including facial rejuvenation and body contouring procedures.
In addition to her clinical commitment, Dr. Nguyen has basic science and clinical research interests in lymphedema and breast reconstruction. She has published articles in peer review journals, presented at national and international professional meetings and has authored book chapters in various plastic surgery textbooks. She also enjoys volunteering on overseas medical missions and participating in medical charity activities. -
Hoang Minh Hieu Nguyen
MD Student with Scholarly Concentration in Molecular Basis of Medicine / Surgery, expected graduation Spring 2030
BioHoang Minh Hieu Nguyen, from Di Linh, Vietnam, is pursuing an MD at Stanford School of Medicine. They earned a bachelor’s degree in neuroscience from Middlebury College and a master of philosophy in clinical neurosciences from the University of Cambridge. Hieu aspires to combine science, the arts, and entrepreneurship to improve healthcare quality and access for global populations burdened by chronic disease. Hieu has contributed to advancing our understanding of cancer and neurodegenerative diseases through research at Middlebury College, Rockefeller University, Memorial Sloan Kettering Cancer Center, University of Cambridge, and Dana-Farber Cancer Institute. As a Social Entrepreneurship Fellow at Middlebury, they collaborated with the Kenyan Ministry of Health and the World Telehealth Initiative to establish Kenya’s first telemedicine system. This program provides lifesaving services, including dialysis, to Longisa, where such services were once unreachable.
